Chargement en cours...

Bleomycin in Hodgkin's Lymphoma – A Boon or a Bane? – A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma

INTRODUCTION: Hodgkin's lymphoma (HL) is one of the most curable malignancies with cure rates of above 85% across all stages. Bleomycin containing regimen is routinely employed in the treatment of HL. Pulmonary toxicity due to this drug is the most feared side effect in these regimens where the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Indian J Palliat Care
Auteurs principaux: Udupa, Chethana Babu K, Koteshwar, Prakashini, Udupa, Karthik S
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer - Medknow 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6812434/
https://ncbi.nlm.nih.gov/pubmed/31673206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/IJPC.IJPC_107_19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!